A New York court found enough evidence to continue with the defamation lawsuit filed by Spanish pharmaceutical company ...

MADRID (Reuters) -A New York court has found enough evidence to proceed with a defamation lawsuit filed by Grifols against ...

Grifols (GRFS) secures a win in its defamation lawsuit against Gotham City Research in the U.S. Read more here.

Grifols offers compelling long-term upside, with potential returns exceeding 200% as the company recovers and grows earnings.

Mason Capital owns ~3% of Grifols A shares. We are aligned with the current Board and are supportive of the recommended slate of director candidates for election at the AGM. We appreciate the ...

The FDA cleared an investigational new drug application for a phase 2 trial of GRF312 ophthalmic solution, an immunoglobulin ...

Grifols GRF-0.39%decrease; red down pointing triangle said it plans to outline its strategy as a standalone company after Brookfield Asset Management dropped out of talks for a 6.45 billion-euro ...

The Grifols family has held "very preliminary talks" through several investment firms over a potential takeover bid, according to a source close to the pharmaceutical company's reference shareholders.

MADRID (Reuters) -A New York court has found enough evidence to proceed with a defamation lawsuit filed by Grifols against short seller Gotham City Research, though it dismissed many of the ...